Industry Virtual Symposium
Advancing care in alpha-1 antitrypsin deficiency: Working towards meeting holistic patient needs
Organized by : Takeda Pharmaceuticals International GmbH
Chairs
M. Miravitlles
Barcelona (CT)
(Spain)
13:00
Introduction from the Chair: AATD disease background and EARCO Registry data
M. Miravitlles (Barcelona (CT), Spain)
1
2332
13:10
ARALAST® NP (RYMPHYSIA®) [Alpha-1 Proteinase Inhibitor (Human)] Clinical Efficacy Study: Advancing research in patients with AATD
J. Homsy (Cambridge, United States)
2
2333
13:20
Working towards holistic management of AATD: A lung and liver disease
V. Clark (Gainesville, United States)
3
2334
13:30
A patient’s vision for the future of care in AATD. Can we get there, and how?
F. Willersinn (Bruxelles, Belgium)
4
2335
13:40
Panel discussion: Moving forward together: Priorities for the advancement of care in AATD
M. Miravitlles (Barcelona (CT), Spain)J. Homsy (Cambridge, United States)V. Clark (Gainesville, United States)F. Willersinn (Bruxelles, Belgium)
5
2336
13:55
Summary and close
M. Miravitlles (Barcelona (CT), Spain)
6
2337
. . .
